________________________________________________________________________________________________________________________________

(C) Wolf G Kroner 2013 - Charles David NicholsonIndustrial Bioscience:
Solutions marketing never dreamt of…
-
Bayer CropScience: Hidden Potentials, Revaluation of IP Assets, and Substantial Changes in R&D

November 2013. Agrochemical and seed companies have long thought of themselves as ‘spider in the web’. Today downstream customers like wholesalers, manufacturers of agro-equipment, or insurers have a much greater say, if and which of many innovations in bioscience reach the farming sector. How does such an eco-system affect R&D strategy and day-to-day operations of Bayer CropScience? In the exclusive interview with B2Bioworld Dr David Nicholson, formerly in the pharmaceutical industry and Head of R&D Bayer CropScience until 2014 offers fresh insight and a substantiated assessment of what the company’s mid-term future might look like.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 8 pages
•  Overview on Bayer CropScience Manufacturing and R&D Sites Worldwide (as of April 2013)
•  Coming to terms with a cross-grained eco-system - Comment

Full Company License enquire here

Back to section

Related Editorial Articles

Sandro Aruffo’s Syngenta Legacy
The late Sandro Aruffo and Robert Berendes, Head of Business Development in candid conversation

Teeth to the Convention on Biological Diversity
Christian Wichard, Deputy Director General of WIPO on its role in enforcing compliance with access and benefit sharing requirements

TALEs, Zinc Fingers, or Meganucleases
A Practice View from Crop Research and Breeding

Plant Genetic Engineering: It's not as simple as Yes or No !
Nobel Prize winner Prof. Christiane Nüsslein-Volhard Warns of GMO-populism and researchers not standing up. Exclusive interview for readers of B2Bioworld

Plants are Nature's Best Chemists
Industrial plant biotechnology is an interdisciplinary toolbox which combines the best approaches in conventional as well as organic agriculture, in industrial production, plant molecular biology, and engineering

Moving Plant Bioscience to Climate-friendly States
Michiel van Lookeren Campagne, Past Global Head of Bayer CropScience BioScience Research

Sustainable Crop Protection
Rid Eastern Europe, the Caucasus and Central Asia of obsolete pesticides

Synthetic Genomics: Autochthon Biotechnology
Commercialisation Strategies for Functional Food, Feed and Biofuels from Algae by James Flatt, CTO Synthetic Genomics

Is that worth a dollar, or a million dollars?
Ed Torres, Managing Director of Lilly Ventures on the Fund’s input to Eli Lilly’s business development

Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on
Michael Schulz, CFO and Compliance Officer of Bayer CropScience describes the workings of the system

GMO Ban to Protect Hungary’s Agro-Industry Against Competition

Improving the IP System on a global scale: A view from Japan
Prof. Sadao Nagaoka, Institute of Innovation Research, and Chief Policy Adviser to the Japanese Government

Patenting Stem Cells – Behind the Front Stages
The patentability of stem cells is of continuing debate. The article outlines the legal approach to stem cells as it informs solving juridical problems

Resolving the Innovation Paradox
Günter von Au, Board Member Clariant AG and past CSO of Süd-Chemie